{"transactions":[{"id":730164,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T20:49:39.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":59000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":59000,"derivative":{"exercise_price":2.96,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":59000},"source":{"system":"sec-edgar","filing":"0001610717-26-000277","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387521/000161071726000277/form4.xml","form_type":"4"}},{"id":763350,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-26T20:19:45.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":17084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control."}],"balance_after":17084,"derivative":{"exercise_price":34.35,"expiration_date":"2036-05-20","underlying":"Class A Common Stock","underlying_shares":17084},"source":{"system":"sec-edgar","filing":"0001387521-26-000002","document":"form4-05262026_080541.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387521/000138752126000002/form4-05262026_080541.xml","form_type":"4"}},{"id":986660,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-26T21:37:03.000Z","date":"2025-11-25","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option will vest monthly over a three-year period subject to the Reporting Person's continuous service on each vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control."}],"balance_after":25000,"derivative":{"exercise_price":29.43,"expiration_date":"2035-11-24","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-25-300677","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387521/000119312525300677/ownership.xml","form_type":"4"}},{"id":1110378,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-16T20:05:15.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is immediately exercisable in full, but any unvested shares that are purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP). The shares subject to the option will vest in 12 successive equal monthly installments following the grant date, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":50000,"derivative":{"exercise_price":0.503,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-017372","document":"form4-06162025_040611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588925017372/form4-06162025_040611.xml","form_type":"4"}},{"id":1110377,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T20:05:15.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit (\"RSU\") grant that will fully vest on the earlier of (a) June 12, 2026 or (b) the day prior to the 2026 annual meeting of stockholders, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")) through such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":99600,"source":{"system":"sec-edgar","filing":"0001415889-25-017372","document":"form4-06162025_040611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588925017372/form4-06162025_040611.xml","form_type":"4"}},{"id":1111169,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:17:50.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2026 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":38000,"derivative":{"exercise_price":2.82,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001610717-25-000212","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387521/000161071725000212/form4.xml","form_type":"4"}},{"id":1488915,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:25:28.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is immediately exercisable in full, but any unvested shares that are purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP). The shares subject to the option will vest in 12 successive equal monthly installments following the grant date, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":50000,"derivative":{"exercise_price":0.5676,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-015759","document":"form4-06062024_080624.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588924015759/form4-06062024_080624.xml","form_type":"4"}},{"id":1488914,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:25:28.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit (\"RSU\") grant that will fully vest on the earlier of (a) June 4, 2025 or (b) the day prior to the 2025 annual meeting of stockholders, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")) through such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":74600,"source":{"system":"sec-edgar","filing":"0001415889-24-015759","document":"form4-06062024_080624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588924015759/form4-06062024_080624.xml","form_type":"4"}},{"id":1501885,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-24T20:12:52.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":67000,"derivative":{"exercise_price":3.28,"exercise_date":"2024-05-23","expiration_date":"2034-05-23","underlying":"Common Shares","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001447028-24-000053","document":"wk-form4_1716581555.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000053/wk-form4_1716581555.xml","form_type":"4"}},{"id":1510712,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-17T21:34:02.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":38000,"derivative":{"exercise_price":1.96,"expiration_date":"2034-05-14","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001610717-24-000245","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387521/000161071724000245/form4.xml","form_type":"4"}},{"id":1851611,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T21:54:26.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2024 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.57,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001610717-23-000183","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387521/000161071723000183/form4.xml","form_type":"4"}},{"id":1868077,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-05T20:50:16.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":27750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is immediately exercisable in full, but any unvested shares that are purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP). The shares subject to the option will vest in 12 successive equal monthly installments following the grant date, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":27750,"derivative":{"exercise_price":1.11,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":27750},"source":{"system":"sec-edgar","filing":"0001209191-23-034401","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919123034401/doc4.xml","form_type":"4"}},{"id":1868076,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T20:50:16.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":13900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit grant that will fully vest on the earlier of (a) June 1, 2024 or (b) the day prior to the 2024 annual meeting of stockholders, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")) through such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":49600,"source":{"system":"sec-edgar","filing":"0001209191-23-034401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919123034401/doc4.xml","form_type":"4"}},{"id":1876386,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-26T20:06:54.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 24, 2023, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":55000,"derivative":{"exercise_price":2.56,"exercise_date":"2023-05-24","expiration_date":"2033-05-24","underlying":"Common Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001447028-23-000040","document":"wk-form4_1685131561.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000040/wk-form4_1685131561.xml","form_type":"4"}},{"id":2227077,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T20:06:39.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.72,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001567619-22-013073","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387521/000156761922013073/doc1.xml","form_type":"4"}},{"id":2255142,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-26T20:16:24.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 25, 2022, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":41000,"derivative":{"exercise_price":2.25,"exercise_date":"2022-05-25","expiration_date":"2032-05-25","underlying":"Common Shares","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0001447028-22-000036","document":"wf-form4_165359615932033.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702822000036/wf-form4_165359615932033.xml","form_type":"4"}},{"id":2366624,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-01T22:11:24.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is immediately exercisable in full, but any unvested shares that are purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP). The shares subject to the option will vest in 12 successive equal monthly installments following the grant date, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":25000,"derivative":{"exercise_price":5.9,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-014145","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919122014145/doc4.xml","form_type":"4"}},{"id":2366623,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-01T22:11:24.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit (\"RSU\") grant that will fully vest on the first anniversary of the grant date, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")) through such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,667 shares subject to the Reporting Person's November 22, 2019 RSU grant that will vest in one final annual installment on November 22, 2022, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":35700,"source":{"system":"sec-edgar","filing":"0001209191-22-014145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919122014145/doc4.xml","form_type":"4"}},{"id":2663114,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T22:45:32.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":7.13,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-21-012368","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387521/000156761921012368/doc1.xml","form_type":"4"}},{"id":2679210,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-06-07T20:25:02.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on June 3, 2021, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options are fully vested and exercisable as of the date of the grant."}],"balance_after":22000,"derivative":{"exercise_price":2.95,"exercise_date":"2021-06-03","expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001447028-21-000042","document":"wf-form4_162309748590209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702821000042/wf-form4_162309748590209.xml","form_type":"4"}},{"id":2827641,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-02T02:01:29.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":16400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP, as amended). The shares subject to the option vest in 12 successive equal monthly installments upon the Reporting Person's completion of each month of Continuous Service (as defined in the 2018 EIP, as amended) over the 12-month period measured from the grant date and subject to acceleration as provided in the 2018 EIP, as amended."}],"balance_after":16400,"derivative":{"exercise_price":11.19,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":16400},"source":{"system":"sec-edgar","filing":"0001209191-21-015508","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121015508/doc4.xml","form_type":"4"}},{"id":2827640,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-02T02:01:29.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":8200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of restricted stock units (\"RSUs\"). The RSUs will fully vest on the first anniversary of the date of grant, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP, as amended\")), through such date and subject to acceleration as provided in the 2018 EIP, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 3,333 shares of common stock issuable upon settlement of RSUs granted to the Reporting Person on November 22, 2019 representing two remaining vesting tranches from such RSU grant with such RSUs vesting with respect to 1,666 shares on November 22, 2021 and 1,667 shares on November 22, 2022; and (b) 10,000 shares of common stock issuable upon settlement of RSUs subject to Reporting Person's May 18, 2020 RSU grant that will fully vest on the earlier of (x) May 18, 2021 (the first anniversary of the date of grant) or (y) the day prior to the Issuer's 2021 annual stockholders meeting.  The vesting of all such RSUs is subject to the Reporting Person's Continuous Service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended."}],"balance_after":23200,"source":{"system":"sec-edgar","filing":"0001209191-21-015508","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121015508/doc4.xml","form_type":"4"}},{"id":3104035,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T16:03:54.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2021 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":8.35,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-20-012433","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387521/000156761920012433/doc1.xml","form_type":"4"}},{"id":3125201,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-03T20:28:16.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP, as amended). The shares subject to the option vest in 12 successive equal monthly installments upon the Reporting Person's completion of each month of Continuous Service (as defined in the 2018 EIP, as amended) over the 12-month period measured from the grant date and subject to acceleration as provided in the 2018 EIP, as amended."}],"balance_after":20000,"derivative":{"exercise_price":10.46,"expiration_date":"2030-05-17","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-034020","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120034020/doc4a.xml","form_type":"4/A","original_submission_date":"2020-05-20"}},{"id":3125200,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-03T20:28:16.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of restricted stock units (\"RSUs\"). The RSUs will fully vest on the earlier of (x) May 18, 2021 (the first anniversary of the date of grant) or (y) the day prior to the 2021 annual stockholders meeting, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP, as amended\")), through such date and subject to acceleration as provided in the 2018 EIP, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"This Form 4/A is being filed solely to correct the stated grant amounts which were erroneously reported on Form 4 filed on behalf of the Reporting Person on May 20, 2020.  Pursuant to the 2018 EIP, as amended, and the Automatic Grant Program for Non-Employee Directors thereunder, the annual grant amounts increased effective with the approval of the 2018 EIP, as amended, by the stockholders of the Issuer on May 18, 2020.  Such previously filed Form 4 incorrectly stated grant amounts pursuant to the Automatic Grant Program for Non-Employee Directors prior to such amendment and restatement of the 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 5,000 shares of common stock issuable upon settlement of RSUs granted to the Reporting Person on November 22, 2019. Such RSUs will vest with respect to 1/3rd of the shares in three equal annual installments over the three-year period measured from the date of grant, subject to the Reporting Person's Continuous Service  (as defined in the 2018 EIP, as amended) through such date and subject to acceleration as provided in the 2018 EIP, as amended."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-20-034020","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120034020/doc4a.xml","form_type":"4/A","original_submission_date":"2020-05-20"}},{"id":3128974,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-06-01T21:04:44.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 28, 2020, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options are fully vested and exercisable as of the date of the grant."}],"balance_after":22000,"derivative":{"exercise_price":2.16,"exercise_date":"2020-05-28","expiration_date":"2030-05-28","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001447028-20-000069","document":"wf-form4_159104546646108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702820000069/wf-form4_159104546646108.xml","form_type":"4"}},{"id":3141418,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-20T21:17:46.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's service on the Board of the Directors of the Issuer. The shares subject to the option vest in 12 successive equal monthly installments upon the Reporting Person's completion of each month of Board service over the 12-month period measured from the grant date."}],"balance_after":15000,"derivative":{"exercise_price":10.46,"expiration_date":"2030-05-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-030956","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120030956/doc4.xml","form_type":"4"}},{"id":3141417,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:17:46.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of restricted stock units (\"RSUs\"). The RSUs will fully vest on the earlier of (x) May 18, 2021 (the first anniversary of the date of grant) or (y) the day prior to the 2021 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,000 shares of common stock issuable upon settlement of RSUs granted to the Reporting Person on November 22, 2019. Such RSUs will vest with respect to 1/3rd of the shares in three equal annual installments over the three-year period measured from the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001209191-20-030956","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120030956/doc4.xml","form_type":"4"}},{"id":3359235,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-26T21:13:12.000Z","date":"2019-11-22","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's service on the Board of Directors of the Issuer. The shares subject to the option vest in 36 successive equal monthly installments upon the Reporting Person's completion of each month of Board service over the 36-month period measured from the grant date."}],"balance_after":30000,"derivative":{"exercise_price":9.81,"expiration_date":"2029-11-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-058100","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119058100/doc4.xml","form_type":"4"}},{"id":3359234,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-26T21:13:12.000Z","date":"2019-11-22","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of restricted stock units (\"RSUs\"). The RSUs will vest with respect to 1/3rd of the shares in three equal annual installments over the three-year period measured from the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-19-058100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119058100/doc4.xml","form_type":"4"}},{"id":3433124,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-08-20T20:16:42.000Z","date":"2019-08-17","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on August 16, 2019, the trading day immediately preceding the date of the grant."}],"balance_after":22000,"derivative":{"exercise_price":1.5,"exercise_date":"2019-08-17","expiration_date":"2029-08-17","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001447028-19-000053","document":"wf-form4_156633218636070.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702819000053/wf-form4_156633218636070.xml","form_type":"4"}},{"id":3481025,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T18:01:52.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2020 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":11.31,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001567619-19-013822","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387521/000156761919013822/doc1.xml","form_type":"4"}},{"id":3717515,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-27T17:42:44.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest on each monthly anniversary measured from December 20, 2018 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":28000,"derivative":{"exercise_price":14.04,"expiration_date":"2028-12-19","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001567619-18-008731","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387521/000156761918008731/doc1.xml","form_type":"4"}},{"id":3785851,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Share Option (Right to Buy)","published_at":"2018-10-22T17:31:15.000Z","date":"2018-10-18","kind":"grant","acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows:  1/3 on 10/18/2019; 1/3 on 10/18/2020; and 1/3 on 10/18/2021."}],"balance_after":44000,"derivative":{"exercise_price":4.71,"expiration_date":"2028-10-18","underlying":"Common Shares","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001567619-18-004376","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000156761918004376/doc1.xml","form_type":"4"}},{"id":418298,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2018-02-23T23:41:02.000Z","date":"2018-02-21","kind":"gift","acquired":true,"shares":2323,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares gifted to family trust."}],"balance_after":132083,"source":{"system":"sec-edgar","filing":"0001127602-18-008130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008130/form4.xml","form_type":"4"}},{"id":418297,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2018-02-23T23:41:02.000Z","date":"2018-02-21","kind":"gift","acquired":false,"shares":2323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares gifted to family trust."}],"balance_after":5393,"source":{"system":"sec-edgar","filing":"0001127602-18-008130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008130/form4.xml","form_type":"4"}},{"id":418296,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2018-02-23T23:41:02.000Z","date":"2018-02-21","kind":"tax_withholding","acquired":false,"shares":1647,"price":80.69,"value":132896.43,"ownership":{"direct":true},"balance_after":7716,"source":{"system":"sec-edgar","filing":"0001127602-18-008130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008130/form4.xml","form_type":"4"}},{"id":418295,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2018-02-23T23:41:02.000Z","date":"2018-02-21","kind":"grant","acquired":true,"shares":1581,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2015. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors."}],"balance_after":9363,"source":{"system":"sec-edgar","filing":"0001127602-18-008130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008130/form4.xml","form_type":"4"}},{"id":418294,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2018-02-23T23:41:02.000Z","date":"2018-02-21","kind":"grant","acquired":true,"shares":4846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 1, 2016, and February 2, 2017. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until such individual satisfies the applicable service-vesting requirements by continuing in the Issuer's employ through December 31, 2018 and December 31, 2019, respectively."}],"balance_after":7782,"source":{"system":"sec-edgar","filing":"0001127602-18-008130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008130/form4.xml","form_type":"4"}},{"id":418293,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2018-02-23T23:41:02.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":221,"price":62.3475,"value":13778.7975,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan."}],"balance_after":2936,"source":{"system":"sec-edgar","filing":"0001127602-18-008130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008130/form4.xml","form_type":"4"}},{"id":419638,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-02-06T01:51:08.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":75490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":75490,"derivative":{"exercise_price":83.49,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":75490},"source":{"system":"sec-edgar","filing":"0001127602-18-004158","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218004158/form4.xml","form_type":"4"}},{"id":420418,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-01-18T23:31:52.000Z","date":"2018-01-16","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":21.575,"expiration_date":"2018-01-30","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001127602-18-002122","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218002122/form4.xml","form_type":"4"}},{"id":420417,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2018-01-18T23:31:52.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":24843,"price":80.9925,"value":2012096.6775,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $80.57 to $81.55.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":2715,"source":{"system":"sec-edgar","filing":"0001127602-18-002122","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218002122/form4.xml","form_type":"4"}},{"id":420416,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2018-01-18T23:31:52.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":75157,"price":79.9961,"value":6012266.8877,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $79.56 to $80.56.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":27558,"source":{"system":"sec-edgar","filing":"0001127602-18-002122","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218002122/form4.xml","form_type":"4"}},{"id":420415,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2018-01-18T23:31:52.000Z","date":"2018-01-16","kind":"exercise","acquired":true,"shares":100000,"price":21.575,"value":2157500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":102715,"source":{"system":"sec-edgar","filing":"0001127602-18-002122","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218002122/form4.xml","form_type":"4"}},{"id":422311,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-11-14T00:57:43.000Z","date":"2017-11-09","kind":"gift","acquired":true,"shares":1327,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":129760,"source":{"system":"sec-edgar","filing":"0001127602-17-031967","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031967/form4.xml","form_type":"4"}},{"id":422310,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-11-14T00:57:43.000Z","date":"2017-11-09","kind":"gift","acquired":false,"shares":1327,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2715,"source":{"system":"sec-edgar","filing":"0001127602-17-031967","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031967/form4.xml","form_type":"4"}},{"id":422309,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-11-14T00:57:43.000Z","date":"2017-11-09","kind":"tax_withholding","acquired":false,"shares":1373,"price":73.02,"value":100256.46,"ownership":{"direct":true},"balance_after":4042,"source":{"system":"sec-edgar","filing":"0001127602-17-031967","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031967/form4.xml","form_type":"4"}},{"id":422308,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-11-14T00:57:43.000Z","date":"2017-11-09","kind":"grant","acquired":true,"shares":2700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Issuance of common stock upon vesting of certain performance share awards on November 9, 2017."}],"balance_after":5415,"source":{"system":"sec-edgar","filing":"0001127602-17-031967","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031967/form4.xml","form_type":"4"}},{"id":422399,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Restricted Stock Unit","published_at":"2017-11-07T22:47:51.000Z","date":"2017-11-05","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."}],"balance_after":4460,"derivative":{"underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001127602-17-031522","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031522/form4.xml","form_type":"4"}},{"id":422398,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-11-07T22:47:51.000Z","date":"2017-11-05","kind":"gift","acquired":true,"shares":2288,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares gifted to family trust."}],"balance_after":128433,"source":{"system":"sec-edgar","filing":"0001127602-17-031522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031522/form4.xml","form_type":"4"}},{"id":422397,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-11-07T22:47:51.000Z","date":"2017-11-05","kind":"gift","acquired":false,"shares":2288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares gifted to family trust."}],"balance_after":2715,"source":{"system":"sec-edgar","filing":"0001127602-17-031522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031522/form4.xml","form_type":"4"}},{"id":422396,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-11-07T22:47:51.000Z","date":"2017-11-05","kind":"tax_withholding","acquired":false,"shares":2212,"price":73.46,"value":162493.52,"ownership":{"direct":true},"balance_after":5003,"source":{"system":"sec-edgar","filing":"0001127602-17-031522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031522/form4.xml","form_type":"4"}},{"id":422395,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-11-07T22:47:51.000Z","date":"2017-11-05","kind":"exercise","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7215,"source":{"system":"sec-edgar","filing":"0001127602-17-031522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031522/form4.xml","form_type":"4"}},{"id":423624,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-09-05T21:31:37.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":21,"expiration_date":"2017-10-22","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001127602-17-026989","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217026989/form4.xml","form_type":"4"}},{"id":423623,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-09-05T21:31:37.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":16700,"price":83.6392,"value":1396774.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $83.51 to $83.91.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":2715,"source":{"system":"sec-edgar","filing":"0001127602-17-026989","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217026989/form4.xml","form_type":"4"}},{"id":423622,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-09-05T21:31:37.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":43300,"price":83.0142,"value":3594514.86,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices reported for the transactions reported here range from $82.50 to $83.50.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":19415,"source":{"system":"sec-edgar","filing":"0001127602-17-026989","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217026989/form4.xml","form_type":"4"}},{"id":423621,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-09-05T21:31:37.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":60000,"price":21,"value":1260000.0,"ownership":{"direct":true},"balance_after":62715,"source":{"system":"sec-edgar","filing":"0001127602-17-026989","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217026989/form4.xml","form_type":"4"}},{"id":423737,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-08-31T17:55:20.000Z","date":"2017-08-15","kind":"gift","acquired":true,"shares":115,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares gifted to family trust."}],"balance_after":126145,"source":{"system":"sec-edgar","filing":"0001127602-17-026760","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217026760/form4.xml","form_type":"4"}},{"id":423736,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-08-31T17:55:20.000Z","date":"2017-08-15","kind":"gift","acquired":false,"shares":115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares gifted to family trust."}],"balance_after":2715,"source":{"system":"sec-edgar","filing":"0001127602-17-026760","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217026760/form4.xml","form_type":"4"}},{"id":423735,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-08-31T17:55:20.000Z","date":"2017-08-15","kind":"grant","acquired":true,"shares":115,"price":59.7635,"value":6872.8025,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan."}],"balance_after":2830,"source":{"system":"sec-edgar","filing":"0001127602-17-026760","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217026760/form4.xml","form_type":"4"}},{"id":424121,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Restricted Stock Unit","published_at":"2017-08-14T22:53:26.000Z","date":"2017-08-10","kind":"exercise","acquired":false,"shares":820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."}],"balance_after":8960,"derivative":{"underlying":"Common Stock","underlying_shares":820},"source":{"system":"sec-edgar","filing":"0001127602-17-025600","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217025600/form4.xml","form_type":"4"}},{"id":424120,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-08-14T22:53:26.000Z","date":"2017-08-10","kind":"gift","acquired":true,"shares":525,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares gifted to family trust."}],"balance_after":126030,"source":{"system":"sec-edgar","filing":"0001127602-17-025600","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217025600/form4.xml","form_type":"4"}},{"id":424119,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-08-14T22:53:26.000Z","date":"2017-08-10","kind":"gift","acquired":false,"shares":525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares gifted to family trust."}],"balance_after":2715,"source":{"system":"sec-edgar","filing":"0001127602-17-025600","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217025600/form4.xml","form_type":"4"}},{"id":424118,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-08-14T22:53:26.000Z","date":"2017-08-10","kind":"tax_withholding","acquired":false,"shares":295,"price":72.7,"value":21446.5,"ownership":{"direct":true},"balance_after":3240,"source":{"system":"sec-edgar","filing":"0001127602-17-025600","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217025600/form4.xml","form_type":"4"}},{"id":424117,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-08-14T22:53:26.000Z","date":"2017-08-10","kind":"exercise","acquired":true,"shares":820,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3535,"source":{"system":"sec-edgar","filing":"0001127602-17-025600","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217025600/form4.xml","form_type":"4"}},{"id":429892,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-02-22T02:25:31.000Z","date":"2017-02-16","kind":"gift","acquired":true,"shares":4354,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares gifted to family trust."}],"balance_after":125505,"source":{"system":"sec-edgar","filing":"0001127602-17-007560","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217007560/form4.xml","form_type":"4"}},{"id":429891,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-02-22T02:25:31.000Z","date":"2017-02-16","kind":"gift","acquired":false,"shares":4354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares gifted to family trust."}],"balance_after":2715,"source":{"system":"sec-edgar","filing":"0001127602-17-007560","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217007560/form4.xml","form_type":"4"}},{"id":429890,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-02-22T02:25:31.000Z","date":"2017-02-16","kind":"tax_withholding","acquired":false,"shares":2053,"price":70.31,"value":144346.43,"ownership":{"direct":true},"balance_after":7069,"source":{"system":"sec-edgar","filing":"0001127602-17-007560","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217007560/form4.xml","form_type":"4"}},{"id":429889,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-02-22T02:25:31.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":1022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2014. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors."}],"balance_after":9122,"source":{"system":"sec-edgar","filing":"0001127602-17-007560","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217007560/form4.xml","form_type":"4"}},{"id":429888,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-02-22T02:25:31.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":1161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 1, 2015, and February 1, 2016. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until such individual satisfies the applicable service-vesting requirements by continuing in the Issuer's employ through December 31, 2017 and December 31, 2018, respectively."}],"balance_after":8100,"source":{"system":"sec-edgar","filing":"0001127602-17-007560","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217007560/form4.xml","form_type":"4"}},{"id":429887,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Common Stock","published_at":"2017-02-22T02:25:31.000Z","date":"2017-02-15","kind":"grant","acquired":true,"shares":213,"price":59.33,"value":12637.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan."}],"balance_after":6939,"source":{"system":"sec-edgar","filing":"0001127602-17-007560","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217007560/form4.xml","form_type":"4"}},{"id":430872,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-02-07T02:48:26.000Z","date":"2017-02-02","kind":"grant","acquired":true,"shares":42390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":42390,"derivative":{"exercise_price":72.25,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":42390},"source":{"system":"sec-edgar","filing":"0001127602-17-004212","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217004212/form4.xml","form_type":"4"}},{"id":432645,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"officer":true,"officer_title":"EVP Worldwide Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-12-13T22:58:42.000Z","date":"2016-12-10","kind":"grant","acquired":true,"shares":28040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":28040,"derivative":{"exercise_price":72.7,"expiration_date":"2026-12-10","underlying":"Common Stock","underlying_shares":28040},"source":{"system":"sec-edgar","filing":"0001127602-16-069950","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216069950/form4.xml","form_type":"4"}},{"id":582232,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-04-26T17:25:58.000Z","date":"2007-04-24","kind":"exercise","acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vested over a five year period with 20% vesting January 18, 2002, the first anniversary of the grant. The options continued to vest in quarterly installments over the next four years, and was fully vested as of January 18, 2006."}],"balance_after":7300,"derivative":{"exercise_price":7.3985,"expiration_date":"2011-01-17","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001179110-07-008457","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008457/edgar.xml","form_type":"4"}},{"id":582231,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-04-26T17:25:58.000Z","date":"2007-04-24","kind":"sale","acquired":false,"shares":300,"price":83.24,"value":24972.0,"ownership":{"direct":true},"balance_after":1029,"source":{"system":"sec-edgar","filing":"0001179110-07-008457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008457/edgar.xml","form_type":"4"}},{"id":582230,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-04-26T17:25:58.000Z","date":"2007-04-24","kind":"sale","acquired":false,"shares":200,"price":83.23,"value":16646.0,"ownership":{"direct":true},"balance_after":1329,"source":{"system":"sec-edgar","filing":"0001179110-07-008457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008457/edgar.xml","form_type":"4"}},{"id":582229,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-04-26T17:25:58.000Z","date":"2007-04-24","kind":"sale","acquired":false,"shares":400,"price":83.22,"value":33288.0,"ownership":{"direct":true},"balance_after":1529,"source":{"system":"sec-edgar","filing":"0001179110-07-008457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008457/edgar.xml","form_type":"4"}},{"id":582228,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-04-26T17:25:58.000Z","date":"2007-04-24","kind":"sale","acquired":false,"shares":800,"price":83.21,"value":66568.0,"ownership":{"direct":true},"balance_after":1929,"source":{"system":"sec-edgar","filing":"0001179110-07-008457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008457/edgar.xml","form_type":"4"}},{"id":582227,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-04-26T17:25:58.000Z","date":"2007-04-24","kind":"sale","acquired":false,"shares":500,"price":83.2,"value":41600.0,"ownership":{"direct":true},"balance_after":2729,"source":{"system":"sec-edgar","filing":"0001179110-07-008457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008457/edgar.xml","form_type":"4"}},{"id":582226,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-04-26T17:25:58.000Z","date":"2007-04-24","kind":"sale","acquired":false,"shares":900,"price":83.19,"value":74871.0,"ownership":{"direct":true},"balance_after":3229,"source":{"system":"sec-edgar","filing":"0001179110-07-008457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008457/edgar.xml","form_type":"4"}},{"id":582225,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-04-26T17:25:58.000Z","date":"2007-04-24","kind":"sale","acquired":false,"shares":1172,"price":83.18,"value":97486.96,"ownership":{"direct":true},"balance_after":4129,"source":{"system":"sec-edgar","filing":"0001179110-07-008457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008457/edgar.xml","form_type":"4"}},{"id":582224,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-04-26T17:25:58.000Z","date":"2007-04-24","kind":"sale","acquired":false,"shares":2015,"price":83.17,"value":167587.55,"ownership":{"direct":true},"balance_after":5301,"source":{"system":"sec-edgar","filing":"0001179110-07-008457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008457/edgar.xml","form_type":"4"}},{"id":582223,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-04-26T17:25:58.000Z","date":"2007-04-24","kind":"sale","acquired":false,"shares":1313,"price":83.16,"value":109189.08,"ownership":{"direct":true},"balance_after":7316,"source":{"system":"sec-edgar","filing":"0001179110-07-008457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008457/edgar.xml","form_type":"4"}},{"id":582222,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-04-26T17:25:58.000Z","date":"2007-04-24","kind":"sale","acquired":false,"shares":200,"price":83.15,"value":16630.0,"ownership":{"direct":true},"balance_after":8629,"source":{"system":"sec-edgar","filing":"0001179110-07-008457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008457/edgar.xml","form_type":"4"}},{"id":582221,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-04-26T17:25:58.000Z","date":"2007-04-24","kind":"sale","acquired":false,"shares":300,"price":83.14,"value":24942.0,"ownership":{"direct":true},"balance_after":8829,"source":{"system":"sec-edgar","filing":"0001179110-07-008457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008457/edgar.xml","form_type":"4"}},{"id":582220,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-04-26T17:25:58.000Z","date":"2007-04-24","kind":"sale","acquired":false,"shares":400,"price":83.13,"value":33252.0,"ownership":{"direct":true},"balance_after":9129,"source":{"system":"sec-edgar","filing":"0001179110-07-008457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008457/edgar.xml","form_type":"4"}},{"id":582219,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-04-26T17:25:58.000Z","date":"2007-04-24","kind":"sale","acquired":false,"shares":200,"price":83.12,"value":16624.0,"ownership":{"direct":true},"balance_after":9529,"source":{"system":"sec-edgar","filing":"0001179110-07-008457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008457/edgar.xml","form_type":"4"}},{"id":582218,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-04-26T17:25:58.000Z","date":"2007-04-24","kind":"sale","acquired":false,"shares":300,"price":83.09,"value":24927.0,"ownership":{"direct":true},"balance_after":9729,"source":{"system":"sec-edgar","filing":"0001179110-07-008457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008457/edgar.xml","form_type":"4"}},{"id":582217,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-04-26T17:25:58.000Z","date":"2007-04-24","kind":"exercise","acquired":true,"shares":9000,"price":7.3985,"value":66586.5,"ownership":{"direct":true},"balance_after":10029,"source":{"system":"sec-edgar","filing":"0001179110-07-008457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008457/edgar.xml","form_type":"4"}},{"id":584868,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2007-03-02T01:34:40.000Z","date":"2007-02-28","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested 20% on July 20, 2001, the first anniversary date of the grant.  The balance vested 5% quarterly thereafter, and was fully vested as of July 20, 2005."}],"balance_after":15712,"derivative":{"exercise_price":9.3438,"expiration_date":"2010-07-20","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001179110-07-005171","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007005171/edgar.xml","form_type":"4"}},{"id":584867,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2007-03-02T01:34:40.000Z","date":"2007-02-28","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares vested 20% on January 26, 2001, the first anniversary date of the grant.  The balance vested 5% quarterly thereafter, and was fully vested as of January 26, 2005."}],"balance_after":0,"derivative":{"exercise_price":7.0782,"expiration_date":"2010-01-26","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001179110-07-005171","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007005171/edgar.xml","form_type":"4"}},{"id":584866,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-03-02T01:34:40.000Z","date":"2007-02-28","kind":"sale","acquired":false,"shares":6000,"price":71.348,"value":428088.0,"ownership":{"direct":true},"balance_after":1029,"source":{"system":"sec-edgar","filing":"0001179110-07-005171","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007005171/edgar.xml","form_type":"4"}},{"id":584865,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-03-02T01:34:40.000Z","date":"2007-02-28","kind":"exercise","acquired":true,"shares":3000,"price":9.3438,"value":28031.4,"ownership":{"direct":true},"balance_after":7029,"source":{"system":"sec-edgar","filing":"0001179110-07-005171","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007005171/edgar.xml","form_type":"4"}},{"id":584864,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Common Stock","published_at":"2007-03-02T01:34:40.000Z","date":"2007-02-28","kind":"exercise","acquired":true,"shares":3000,"price":7.0782,"value":21234.6,"ownership":{"direct":true},"balance_after":4029,"source":{"system":"sec-edgar","filing":"0001179110-07-005171","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007005171/edgar.xml","form_type":"4"}},{"id":588370,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-01-25T01:25:27.000Z","date":"2007-01-22","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a five year period beginning 1/22/2008, the first anniversary of the grant. The options continue to vest in quarterly installments over the next four years, ending on 1/22/2012."}],"balance_after":35000,"derivative":{"exercise_price":65.58,"expiration_date":"2017-01-22","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001179110-07-001888","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007001888/edgar.xml","form_type":"4"}},{"id":588369,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16123,"kind":"person","name":"Meyers James R","position":1,"cik":"0001387521","reported_name":"Meyers James R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Comm Ops North America"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-01-25T01:25:27.000Z","date":"2007-01-22","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a five year period beginning 1/22/2008, the first anniversary of the grant. The options continue to vest in quarterly installments over the next four years, ending on 1/22/2012."}],"balance_after":28000,"derivative":{"exercise_price":65.58,"expiration_date":"2017-01-22","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001179110-07-001888","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007001888/edgar.xml","form_type":"4"}}]}